US 8,613,717

Application 13/084,694 · Granted Dec 24, 2013

Systems and methods for removing and fragmenting undesirable material within a circulatory system

Estimated expiration

February 15, 2029

2y 86d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Aug 6, 2008
+ 20 years
Aug 6, 2028
PTA +193d
Feb 15, 2029
No TD
—
Final
Feb 15, 2029

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
April 12, 2011
Earliest effective filing
August 6, 2008
Issue date
December 24, 2013
PTA
+193 days
Base expiry (before PTA)
August 6, 2028

August 6, 2008 + 20 years = August 6, 2028 + 193 PTA days = February 15, 2029

  • Continuation-in-part of application 12/187,121, filed Aug 6, 2008, issued as US 8,075,510
  • PRO61/015,301 — Provisional — not used for base term
  • PRO61/015,301 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 13/084,694 · US 8,613,717

PatentReply compiles the prosecution history behind US 8,613,717: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8613717

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.